152 related articles for article (PubMed ID: 36002447)
1. Bridging the phenomenological gap between predictive basic-symptoms and attenuated positive symptoms: a cross-sectional network analysis.
Müller H; Betz LT; Kambeitz J; Falkai P; Gaebel W; Heinz A; Hellmich M; Juckel G; Lambert M; Meyer-Lindenberg A; Schneider F; Wagner M; Zink M; Klosterkötter J; Bechdolf A
Schizophrenia (Heidelb); 2022 Aug; 8(1):68. PubMed ID: 36002447
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.
Fusar-Poli P; Cappucciati M; Borgwardt S; Woods SW; Addington J; Nelson B; Nieman DH; Stahl DR; Rutigliano G; Riecher-Rössler A; Simon AE; Mizuno M; Lee TY; Kwon JS; Lam MM; Perez J; Keri S; Amminger P; Metzler S; Kawohl W; Rössler W; Lee J; Labad J; Ziermans T; An SK; Liu CC; Woodberry KA; Braham A; Corcoran C; McGorry P; Yung AR; McGuire PK
JAMA Psychiatry; 2016 Feb; 73(2):113-20. PubMed ID: 26719911
[TBL] [Abstract][Full Text] [Related]
3. Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state.
Schultze-Lutter F; Ruhrmann S; Berning J; Maier W; Klosterkötter J
Schizophr Bull; 2010 Jan; 36(1):182-91. PubMed ID: 18579555
[TBL] [Abstract][Full Text] [Related]
4. Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies.
Schimmelmann BG; Michel C; Martz-Irngartinger A; Linder C; Schultze-Lutter F
World Psychiatry; 2015 Jun; 14(2):189-97. PubMed ID: 26043337
[TBL] [Abstract][Full Text] [Related]
5. Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition.
Staines L; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
BMC Psychiatry; 2021 Jul; 21(1):339. PubMed ID: 34233651
[TBL] [Abstract][Full Text] [Related]
6. Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosis.
Eisenacher S; Rausch F; Ainser F; Englisch S; Becker A; Mier D; Fenske S; Meyer-Lindenberg A; Kirsch P; Zink M
Early Interv Psychiatry; 2018 Aug; 12(4):586-595. PubMed ID: 27169782
[TBL] [Abstract][Full Text] [Related]
7. Basic Symptoms Are Associated With Age in Patients With a Clinical High-Risk State for Psychosis: Results From the PRONIA Study.
Walger H; Antonucci LA; Pigoni A; Upthegrove R; Salokangas RKR; Lencer R; Chisholm K; Riecher-Rössler A; Haidl T; Meisenzahl E; Rosen M; Ruhrmann S; Kambeitz J; Kambeitz-Ilankovic L; Falkai P; Ruef A; Hietala J; Pantelis C; Wood SJ; Brambilla P; Bertolino A; Borgwardt S; Koutsouleris N; Schultze-Lutter F
Front Psychiatry; 2020; 11():552175. PubMed ID: 33312133
[TBL] [Abstract][Full Text] [Related]
8. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
[TBL] [Abstract][Full Text] [Related]
9. The heterogeneity of attenuated and brief limited psychotic symptoms: association of contents with age, sex, country, religion, comorbidities, and functioning.
Theisen C; Rosen M; Meisenzahl E; Koutsouleris N; Lichtenstein T; Ruhrmann S; Kambeitz J; Kambeitz-Ilankovic L; Riecher-Rössler A; Chisholm K; Upthegrove R; Antonucci LA; Bertolino A; Pigoni A; Salokangas RKR; Pantelis C; Wood SJ; Lencer R; Falkai P; Hietala J; Brambilla P; Schmidt A; Andreou C; Borgwardt S; Osman N; Schultze-Lutter F
Front Psychiatry; 2023; 14():1209485. PubMed ID: 37484669
[TBL] [Abstract][Full Text] [Related]
10. Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinations.
Schultze-Lutter F; Renner F; Paruch J; Julkowski D; Klosterkötter J; Ruhrmann S
Psychopathology; 2014; 47(3):194-201. PubMed ID: 24192655
[TBL] [Abstract][Full Text] [Related]
11. The significance of at-risk symptoms for psychosis in children and adolescents.
Schimmelmann BG; Walger P; Schultze-Lutter F
Can J Psychiatry; 2013 Jan; 58(1):32-40. PubMed ID: 23327754
[TBL] [Abstract][Full Text] [Related]
12. DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders.
Salazar de Pablo G; Guinart D; Cornblatt BA; Auther AM; Carrión RE; Carbon M; Jiménez-Fernández S; Vernal DL; Walitza S; Gerstenberg M; Saba R; Lo Cascio N; Brandizzi M; Arango C; Moreno C; Van Meter A; Fusar-Poli P; Correll CU
Front Psychiatry; 2020; 11():568982. PubMed ID: 33192693
[No Abstract] [Full Text] [Related]
13. Age effects on basic symptoms in the community: A route to gain new insight into the neurodevelopment of psychosis?
Schultze-Lutter F; Ruhrmann S; Michel C; Kindler J; Schimmelmann BG; Schmidt SJ
Eur Arch Psychiatry Clin Neurosci; 2020 Apr; 270(3):311-324. PubMed ID: 30361925
[TBL] [Abstract][Full Text] [Related]
14. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?
Nelson B; Yuen K; Yung AR
Schizophr Res; 2011 Jan; 125(1):62-8. PubMed ID: 21074975
[TBL] [Abstract][Full Text] [Related]
15. Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study.
Oliver D; Davies C; Zelaya F; Selvaggi P; De Micheli A; Catalan A; Baldwin H; Arribas M; Modinos G; Crossley NA; Allen P; Egerton A; Jauhar S; Howes OD; McGuire P; Fusar-Poli P
Front Psychiatry; 2023; 14():1092213. PubMed ID: 36970257
[TBL] [Abstract][Full Text] [Related]
16. Subjective experience and meaning of delusions in psychosis: a systematic review and qualitative evidence synthesis.
Ritunnano R; Kleinman J; Whyte Oshodi D; Michail M; Nelson B; Humpston CS; Broome MR
Lancet Psychiatry; 2022 Jun; 9(6):458-476. PubMed ID: 35523211
[TBL] [Abstract][Full Text] [Related]
17. Adolescents and adults at clinical high-risk for psychosis: age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms.
Gerstenberg M; Theodoridou A; Traber-Walker N; Franscini M; Wotruba D; Metzler S; Müller M; Dvorsky D; Correll CU; Walitza S; Rössler W; Heekeren K
Psychol Med; 2016 Apr; 46(5):1069-78. PubMed ID: 26671170
[TBL] [Abstract][Full Text] [Related]
18. Main Symptomatic Treatment Targets in Suspected and Early Psychosis: New Insights From Network Analysis.
Jimeno N; Gomez-Pilar J; Poza J; Hornero R; Vogeley K; Meisenzahl E; Haidl T; Rosen M; Klosterkötter J; Schultze-Lutter F
Schizophr Bull; 2020 Jul; 46(4):884-895. PubMed ID: 32010940
[TBL] [Abstract][Full Text] [Related]
19. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
[TBL] [Abstract][Full Text] [Related]
20. Age effect on prevalence of ultra-high risk for psychosis symptoms: replication in a clinical sample of an early detection of psychosis service.
Schultze-Lutter F; Hubl D; Schimmelmann BG; Michel C
Eur Child Adolesc Psychiatry; 2017 Nov; 26(11):1401-1405. PubMed ID: 28456857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
